Reinhold, D. ; Kähne, T. ; Steinbrecher, A. ; Wrenger, S. ; Neubert, K. ; Ansorge, S. ; Brocke, S.
Alternative Links zum Volltext:DOIVerlag
| Dokumentenart: | Artikel |
|---|
| Titel eines Journals oder einer Zeitschrift: | Biological Chemistry |
|---|
| Verlag: | WALTER DE GRUYTER & CO |
|---|
| Ort der Veröffentlichung: | BERLIN |
|---|
| Band: | 383 |
|---|
| Nummer des Zeitschriftenheftes oder des Kapitels: | 7-8 |
|---|
| Datum: | 2002 |
|---|
| Institutionen: | Medizin > Lehrstuhl für Neurologie |
|---|
| Identifikationsnummer: | | Wert | Typ |
|---|
| 10.1515/BC.2002.123 | DOI |
|
|---|
| Stichwörter / Keywords: | TRANSFORMING GROWTH-FACTOR-BETA-1 TGF-BETA-1; MESSENGER-RNA EXPRESSION; PWM-STIMULATED PBMC; IN-VIVO; CD26; LYMPHOCYTES; INHIBITORS; GROWTH; SUPPRESSION; SECRETION; autoimmune diseases; CD26; dipeptidyl peptidase IV; T cell activation |
|---|
| Dewey-Dezimal-Klassifikation: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin |
|---|
| Status: | Veröffentlicht |
|---|
| Begutachtet: | Ja, diese Version wurde begutachtet |
|---|
| An der Universität Regensburg entstanden: | Ja |
|---|
| Dokumenten-ID: | 72869 |
|---|
Web of Science
Zusammenfassung
Activated T lymphocytes express high levels of dipeptidyl peptidase IV (DP IV)/CD26. Recent studies support the notion that DP IV may play an important role in the regulation of differentiation and growth of T lymphocytes. This article gives a short overview on DP IV/CD26 expression and effects on immune cells in vitro and in vivo. A major focus of this review are clinical aspects of the function ...
Zusammenfassung
Activated T lymphocytes express high levels of dipeptidyl peptidase IV (DP IV)/CD26. Recent studies support the notion that DP IV may play an important role in the regulation of differentiation and growth of T lymphocytes. This article gives a short overview on DP IV/CD26 expression and effects on immune cells in vitro and in vivo. A major focus of this review are clinical aspects of the function of CD26 on hematopoietic cells and the potential usage of synthetic DP IV inhibitors as therapeutics in inflammatory disorders.